Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

TAFII250 Mouse anti-Human, Clone: 6B3, MilliporeSigma™

Catalog No. 041525MI Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
04-152-5MI 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 04-152-5MI Supplier MilliporeSigma Supplier No. 041525
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

Anti-TAFII250 Antibody, clone 6B3 is a Mouse Monoclonal Antibody for detection of TAFII250 also known as Cell cycle gene 1 protein and has been validated in western blot, immunocytochemistry, immunohistochemistry and immunoprecipitation.
TRUSTED_SUSTAINABILITY

Specifications

Antigen TAFII250
Applications Immunocytochemistry, Immunohistochemistry, Immunoprecipitation, Western Blot
Classification Monoclonal
Clone 6B3
Conjugate Unconjugated
Formulation Purified mouse monoclonal IgG1κ in buffer containing 0.1MTris-Glycine (pH 7.4, 150mM NaCl) with 0.05% sodium azide.
Gene Accession No. NP_004597.2
Gene Symbols TAF1, BA2R, CCG1, CCGS, DYT3, KAT4, N-TAF1, NSCL2, OF, P250, TAF(II)250, TAF2A, TAFII-250, TAFII250, p250
Host Species Mouse
Immunogen Human TAFII250
Purification Method Protein G purfied
Quantity 100 μg
Primary or Secondary Primary
Target Species Human
Content And Storage 2-8°C for one year
Form Purified
Isotype IgG1 κ
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.